KEEPING YOU IN THE LOOP

Libre Life Newsletter

News and stories from the latest edition. Independently written by a T1D community member. Not affiliated with any medtech provider.

Pinned

Libre Life Autumn 2026

October 29, 2026 · Samantha Hooper

Welcome to the Autumn edition of Libre Life, keeping you in the loop with the latest CGM, medtech and diabetes news. In 2026, several medtech companies have been restructuring their businesses, with some looking towards the bigger and potentially more...
A word from the Editor
October 28, 2026

World Diabetes Day 2026: What's it all about and how can you get involved?

World Diabetes Day takes place on 14th November. Find out why we celebrate it, what's happening in 2026 and how PWD, families...
October 27, 2026

Dexcom Backlash: Agree to our terms or lose access to your glucose readings?

Dexcom users were furious after being confronted with app Ts&Cs demanding agreement before they could access glucose readings. The backlash over AI,...
October 23, 2026

New British CGM Sava aims to challenge FreeStyle Libre and Dexcom

British startup Sava Technologies is developing a new CGM using microsensors ten times shorter than conventional sensor filaments. Backed by $36 million...
October 22, 2026

Adding protein to breakfast could reduce glucose spikes in children with Type 1 diabetes

Could adding an egg or cheese to breakfast help prevent glucose spikes? New UK research involving children and teenagers with type 1...
October 15, 2026

For every £1 Diabetes UK received — Just 6½ p was committed to New Research

Diabetes UK received £43.8 million in 2025, but only 6½p in every £1 was committed to new research from its core funds....
October 13, 2026

What Diabetes UK doesn’t make clear about the £50 Million Fund for a Cure

From Redrow's cladding and fire-safety controversies to Conservative Party donations, discover the billionaire behind the £50 million search for a type 1...
September 18, 2026

Novo Nordisk becomes ‘Novo’ as diabetes giant rebrands for health market

Novo Nordisk is adopting the shorter name ‘Novo’ as part of a major global rebrand. Behind the new logo is a wider...
September 6, 2026

Once-weekly insulin for type 2 diabetes: NICE backs a very different kind of diabetes innovation

NICE has backed once-weekly insulin efsitora alfa, branded Onswik, for type 2 diabetes manangement. It could mean 313 fewer basal injections a...